Latest DrugApproval News and Updates : DrugApproval updates, DrugApproval News , DrugApproval around the world

Nishadil

Washington | 19°C (clear sky)

FDA Names New Leaders for Drugs, Vaccines, Tobacco & AI Oversight

Top story

FDA Names New Leaders for Drugs, Vaccines, Tobacco & AI Oversight

In focus

Latest feed

Compass Pathways’ Stock Surges as It Gears Up for FDA Psychedelics Hearing

New Zealand Greenlights MDMA for Severe PTSD Treatment

The Great Biotech Bet: Prediction Markets Clash with Medical Ethics

India's Landmark Approval: Wegovy Cleared for MASH, a Serious Liver Condition

Latest headlines

Wegovy Gets Green Light in India as First‑Line Treatment for MASH, the Liver Condition Touching One‑Third of Indians

Wegovy Gets Green Light in India as First‑Line Treatment for MASH, the Liver Condition Touching One‑Third of Indians

A New Dawn for Thyroid Eye Disease: Viridian Therapeutics' Lumvoa Poised for Transformative Impact

A New Dawn for Thyroid Eye Disease: Viridian Therapeutics' Lumvoa Poised for Transformative Impact

Aurobindo Pharma Secures Landmark USFDA Approval for Generic Tofacitinib: A Game-Changer?

Aurobindo Pharma Secures Landmark USFDA Approval for Generic Tofacitinib: A Game-Changer?

FDA Commissioner Marty Makary's Shock Departure Jolts Washington

FDA Commissioner Marty Makary's Shock Departure Jolts Washington

The Unfolding Saga: Inside the FDA's Scrutiny of the Abortion Pill

The Unfolding Saga: Inside the FDA's Scrutiny of the Abortion Pill

A Critical Voice Departs: Dr. Vinay Prasad's Resignation From FDA Advisory Role

A Critical Voice Departs: Dr. Vinay Prasad's Resignation From FDA Advisory Role

The FDA's Risky Gamble: Incentivizing Speed in Drug Approvals

The FDA's Risky Gamble: Incentivizing Speed in Drug Approvals

Savara Shares Soar as FDA Grants Priority Review for Rare Lung Disorder Therapy

Savara Shares Soar as FDA Grants Priority Review for Rare Lung Disorder Therapy

Unveiling the Truth: Are FDA Drug Studies Truly Robust?

Unveiling the Truth: Are FDA Drug Studies Truly Robust?

A Glimmer of Hope? Why Wall Street is Bullish on ImmunityBio (IBRX) After Key Saudi Approval

A Glimmer of Hope? Why Wall Street is Bullish on ImmunityBio (IBRX) After Key Saudi Approval

A Regulatory Stumble: FDA Puts Brakes on Moderna's Flu Vaccine Hopes

A Regulatory Stumble: FDA Puts Brakes on Moderna's Flu Vaccine Hopes

Summit Therapeutics on the Cusp: A Dual-Action Lung Cancer Drug Faces its Moment of Truth

Summit Therapeutics on the Cusp: A Dual-Action Lung Cancer Drug Faces its Moment of Truth

The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?

The FDA's Bold New Vision: Could One Clinical Trial Be Enough for Drug Approval?

A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance

A New Chapter for Wockhardt? Chairman 'Very Confident' on Novel Antibiotic's USFDA Acceptance

Navigating the Nuances of Cytokinetics: December's Catalyst and the Investment Conundrum

Navigating the Nuances of Cytokinetics: December's Catalyst and the Investment Conundrum

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

When Leadership Takes the Reins: Unpacking the FDA's Unusual Priority Voucher Vote

The Unflinching Hand at the Helm: Richard Pazdur's Enduring Legacy at the FDA

The Unflinching Hand at the Helm: Richard Pazdur's Enduring Legacy at the FDA

The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets

The FDA's Tightening Grip: A Crucible for Biotech's Biggest Bets

The Zynity Enigma: When Innovation Meets Intense Scrutiny at the FDA

The Zynity Enigma: When Innovation Meets Intense Scrutiny at the FDA

The Weight of Expectation: FDA, Obesity Drugs, and the Uneasy Dance Between Speed and Safety

The Weight of Expectation: FDA, Obesity Drugs, and the Uneasy Dance Between Speed and Safety

A Sweeping Change for Little Smiles: Why the FDA Just Banned Unapproved Fluoride for Kids

A Sweeping Change for Little Smiles: Why the FDA Just Banned Unapproved Fluoride for Kids

Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

Unlocking Affordability: The FDA's Bold Play to Turbocharge Generic Drug Access

A Tsunami of Pills: Eli Lilly's Grand Plan to Conquer the Weight Loss Market

A Tsunami of Pills: Eli Lilly's Grand Plan to Conquer the Weight Loss Market

The Long Road to Hope: Anavex's Alzheimer's Drug Hits a Regulatory Wall

The Long Road to Hope: Anavex's Alzheimer's Drug Hits a Regulatory Wall

FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development

FDA Unleashes Game-Changing Incentive: Priority Review Vouchers Set to Revolutionize Drug Development

Under Siege: Whistleblowers Unmask Political Pressures Threatening FDA's Scientific Soul

Under Siege: Whistleblowers Unmask Political Pressures Threatening FDA's Scientific Soul

Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future

Biohaven's Breakthrough Bid: Navigating FDA Flexibility for Spinocerebellar Ataxia's Future

Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug

Biocon Biologics Secures Landmark USFDA Approval for Critical Antibacterial Drug

FDA's Landmark Decision: Mifepristone Secures Full Approval, Reshaping Reproductive Healthcare Landscape

FDA's Landmark Decision: Mifepristone Secures Full Approval, Reshaping Reproductive Healthcare Landscape

Wockhardt Seeks USFDA Nod for Revolutionary Antibiotic Zaynich: A New Hope Against Superbugs

Wockhardt Seeks USFDA Nod for Revolutionary Antibiotic Zaynich: A New Hope Against Superbugs

Historic Shift: FDA Greenlights Generic Abortion Pill, Redefining Access Landscape

Historic Shift: FDA Greenlights Generic Abortion Pill, Redefining Access Landscape

Healthcare's Brink: How a Government Shutdown Threatens HHS, CDC, and FDA

Healthcare's Brink: How a Government Shutdown Threatens HHS, CDC, and FDA

Unveiling the Shadowy Ethics: Former Pharma CEO's FDA Claims Spark Regulatory Outcry

Unveiling the Shadowy Ethics: Former Pharma CEO's FDA Claims Spark Regulatory Outcry

Ozempic Arrives in India: A New Dawn for Type 2 Diabetes Management and Weight Loss

Ozempic Arrives in India: A New Dawn for Type 2 Diabetes Management and Weight Loss

MoonLake Immunotherapeutics Skyrockets: Is a Biotech Buyout Imminent After Breakthrough Skin Drug Trial?

MoonLake Immunotherapeutics Skyrockets: Is a Biotech Buyout Imminent After Breakthrough Skin Drug Trial?

Lupin Achieves Major Milestone: USFDA Grants Tentative Approval for Generic HIV Treatment Drug

Lupin Achieves Major Milestone: USFDA Grants Tentative Approval for Generic HIV Treatment Drug

FDA Greenlights Leucovorin for Cancer Support Amidst Unrelated Autism Treatment Buzz

FDA Greenlights Leucovorin for Cancer Support Amidst Unrelated Autism Treatment Buzz

European Triumph: KalVista and Ionis Celebrate Key Drug Approvals Across the EU

European Triumph: KalVista and Ionis Celebrate Key Drug Approvals Across the EU

Load more